Brain metabolism and neurological symptoms in combined malonic and methylmalonic aciduria

Orphanet J Rare Dis. 2020 Jan 22;15(1):27. doi: 10.1186/s13023-020-1299-7.

Abstract

Combined malonic and methylmalonic aciduria (CMAMMA) is an inborn error of metabolism which has been proposed being a benign condition. However, older patients may present with neurological manifestations such as seizures, memory problems, psychiatric problems and/ or cognitive decline. In fibroblasts from CMAMMA patients we have recently demonstrated a dysregulation of energy metabolism with increased dependency on β-oxidation for energy production. Because of the inability of the brain to rely efficiently on this pathway to retrieve the required energy to a great extent, we hypothesize an alternative disease-causing mechanism that does not only include the accumulation of the metabolites malonic and methylmalonic acids. Here, we suggest a novel hypothesis on the possible pathophysiological mechanism responsible for the development of neurological symptoms in the long-run.

Keywords: ACSF3; Brain energy metabolism; Combined malonic and methylmalonic aciduria; Metabolic flexibility; mtFASII.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Metabolism, Inborn Errors*
  • Brain
  • Humans
  • Metabolism, Inborn Errors*
  • Methylmalonic Acid

Substances

  • Methylmalonic Acid

Supplementary concepts

  • Combined Malonic and Methylmalonic Aciduria